ElevateBio - a technology-driven company focused on powering the creation of life-transforming cell and gene therapies - announced recently the closing of its $401 million Series D financing led by the AyurMaya Capital Management Fund.
Impact Observatory is known as a mission-driven technology company bringing AI/ML algorithms and data to sustainability and environmental risk analysis for governments, non-profit organizations, companies, and markets. To learn more about the company, Pulse 2.0 interviewed Impact Observatory Co-founder and CEO Steve Brumby.
Bryant University announced a significant campus expansion due to a generous real estate donation from neighboring Fidelity Investments. Fidelity donated 100 Salem Street, which is part of their Smithfield corporate campus just across the street from the existing Bryant campus entrance.
Cohere - a leading pioneer in language AI - is a company that empowers every developer and business to build incredible products with world-leading natural language processing (NLP) technology while keeping their data private and secure. Recently the company announced it raised $270 million as part of a Series C round of funding.
Tiugo Technologies is a company that is assembling a portfolio of API-first and market-leading developer platforms focused on content creation and digital collaboration to help them accelerate growth, increase operating efficiency, and fund add-on acquisitions. To learn more about the company, Pulse 2.0 interviewed Tiugo Chief Revenue Officer Scott Heimes.
Digibee - an integration platform as a service (iPaaS) company that helps organizations build flexible and highly scalable integration architecture - announced it received $60 million in Series B funding.
Laudio - a management solution for healthcare - announced recently that it has raised a $13 million Series B funding round led by Define Ventures with participation from existing investors .406 Ventures, InHealth Ventures, MemorialCare Innovation Fund, and TeleTracking Technologies.
Sonio is a company that is known as the only SaaS platform that empowers healthcare professionals to secure prenatal care by combining technological innovation, medical expertise, and collective intelligence. To learn more about the company, Pulse 2.0 interviewed Sonio co-founder and CEO Cécile Brosset.
ODAIA is a leading provider of automated commercial predictive insights trusted by global life sciences organizations that utilizes proprietary data-driven and AI-powered methods to identify distinct population subsets and their healthcare providers in the most efficient way possible. To learn more about the company, Pulse 2.0 interviewed ODAIA CEO and co-founder Philip Poulidis.
Cybersyn is known as a DaaS (data-as-a-service) company that has a mission to make the world's economic data transparent to governments, businesses, and entrepreneurs and enable a new generation of decision-makers. To learn more about the company, Pulse 2.0 interviewed Cybersyn founder and CEO Alex Izydorczyk.
Smartling is an enterprise language translation company that enables customers to localize content across devices and platforms. To learn more about the company, Pulse 2.0 interviewed Smartling CEO Bryan Murphy.
Amify - a leading provider of technology-enabled Amazon optimization and advertising solutions - announced that it has closed its Series B funding round with a total of $10 million in investment. This funding round was led by strategic growth-oriented investors including Mercury Fund, Cincy Tech, and SAAS Ventures along with participation from several undisclosed angel investors.
Meanwhile - the first and only life insurer entirely denominated in a cryptocurrency - announced recently that it raised about $19 million in financing across two seed rounds
Sequoia Capital - one of the largest venture capital firms - announced earlier this week that it would be splitting its global partnership into 3 separate geographic units. For example, Sequoia China will be divided from Europe and the U.S. partnership due to increasingly complex dynamics. Sequoia China and the firm’s Southeast Asian arms are going to become independent businesses by next year.
Keep Aware - a company that is pioneering a human-centric approach to browser security - announced a $2.4 million round led by LiveOak Venture Partners with participation from Runtime Ventures and prominent angel investors in the cybersecurity industry.
Mend - a life sciences and digital health company operating at the intersection of nutrapharma, food as medicine, and behavioral health - announced recently that it has received a round of Series A funding.
VentureFuel is an independent innovation advisory firm that helps the world's best organizations commercialize innovation to ignite change. To learn more about the firm, Pulse 2.0 interviewed VentureFuel Founder and CEO Fred Schonenberg.
Datasembly - a leading provider of real-time product pricing, promotions, and assortment data for retailers and CPG brands - announced it has secured $16 million in funding led by Noro-Moseley Partners with participation from Grotech Ventures, Topmark Partners, and Staley Capital.
Keeta - a new global payments platform offering instant and secure cross-border monetary transactions - recently announced its official launch with $17 million in funding from investors, including Eric Schmidt.
Episode Six (E6) - a global provider of enterprise-grade payment processing and digital ledger infrastructure - announced a $48 million Series C financing led by Avenir
Quanta Therapeutics - a privately-held biopharmaceutical company pioneering targeted therapies to treat RAS-driven cancers - announced recently a $50.7 million Series D financing.
Builder.ai - an AI-powered composable software platform designed to be so simple and accessible that everyday businesses and individuals can turn their ideas into software - announced recently an investment of over $250 million in Series D funding. This new funding round - which was led by Qatar Investment Authority (QIA) takes the total amount raised by the company to over $450 million with an up to 1.8x increase in its valuation.
ReNAgade Therapeutics - a company unlocking the limitless potential for RNA medicines to correct disease - recently announced a $300 million Series A financing round led by MPM BioImpact and F2 Ventures.